1. Home
  2. LCFY vs EVOK Comparison

LCFY vs EVOK Comparison

Compare LCFY & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • EVOK
  • Stock Information
  • Founded
  • LCFY 2009
  • EVOK 2007
  • Country
  • LCFY Australia
  • EVOK United States
  • Employees
  • LCFY N/A
  • EVOK N/A
  • Industry
  • LCFY
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCFY
  • EVOK Health Care
  • Exchange
  • LCFY Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • LCFY 9.9M
  • EVOK 7.1M
  • IPO Year
  • LCFY 2022
  • EVOK 2013
  • Fundamental
  • Price
  • LCFY $7.48
  • EVOK $5.37
  • Analyst Decision
  • LCFY
  • EVOK
  • Analyst Count
  • LCFY 0
  • EVOK 0
  • Target Price
  • LCFY N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • LCFY 21.6K
  • EVOK 8.9K
  • Earning Date
  • LCFY 04-01-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • LCFY N/A
  • EVOK N/A
  • EPS Growth
  • LCFY N/A
  • EVOK N/A
  • EPS
  • LCFY N/A
  • EVOK N/A
  • Revenue
  • LCFY $2,668,385.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • LCFY N/A
  • EVOK $97.35
  • Revenue Next Year
  • LCFY N/A
  • EVOK $99.52
  • P/E Ratio
  • LCFY N/A
  • EVOK N/A
  • Revenue Growth
  • LCFY N/A
  • EVOK 100.35
  • 52 Week Low
  • LCFY $2.20
  • EVOK $3.54
  • 52 Week High
  • LCFY $11.23
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 49.98
  • EVOK 65.36
  • Support Level
  • LCFY $5.80
  • EVOK $4.68
  • Resistance Level
  • LCFY $8.00
  • EVOK $5.40
  • Average True Range (ATR)
  • LCFY 0.67
  • EVOK 0.33
  • MACD
  • LCFY -0.11
  • EVOK 0.07
  • Stochastic Oscillator
  • LCFY 46.80
  • EVOK 97.46

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: